According to the SEC Form 4 filings, RATAJCZAK DONALD R, being in a position of
No biography is available at this moment.
Buys | $95,850 | 4 | 100 |
Sells | $0 | 0 | 0 |
| 2026-02-17 | Sale | ADMA Biologics, Inc. ADMA | President and CEO | 21,000 0.0089% | $16.08 | $337,680 | -0.81% | |
| 2026-02-17 | Sale | Alignment Healthcare, Inc. ALHC | President | 30,000 0.015% | $20.63 | $618,990 | -0.21% | |
| 2026-02-17 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CSO & EVP, Head of Research | 2,041 0.0015% | $331.96 | $677,532 | +0.2% | |
| 2026-02-17 | Sale | Atkore Inc. ATKR | Pres. Safety & Infrastructure | 1,000 0.0029% | $65.78 | $65,780 | +1.06% | |
| 2026-02-17 | Sale | Aura Biosciences, Inc. AURA | Senior Vice President, Finance | 8,549 0.013% | $5.06 | $43,258 | +3.75% | |
| 2026-02-17 | Sale | Aura Biosciences, Inc. AURA | See Remarks | 12,079 0.0183% | $5.05 | $60,999 | +3.96% | |
| 2026-02-17 | Sale | Aura Biosciences, Inc. AURA | Chief Technology Officer | 15,890 0.0241% | $5.05 | $80,245 | +3.96% | |
| 2026-02-17 | Sale | Aura Biosciences, Inc. AURA | Chief Medical Officer | 20,401 0.031% | $5.06 | $103,229 | +3.75% | |
| 2026-02-17 | Sale | Aura Biosciences, Inc. AURA | See Remarks | 47,648 0.0723% | $5.06 | $241,099 | +3.75% | |
| 2026-02-17 | Sale | AeroVironment, Inc. AVAV | director | 500 0.001% | $254.95 | $127,475 | +3.15% | |
| 2026-02-17 | Sale | Avidbank Holdings, Inc. AVBH | director | 5,076 0.0585% | $30.17 | $153,153 | -0.37% | |
| 2026-02-17 | Byline Bancorp, Inc. BY | General Counsel | 750 0.0016% | $33.13 | $24,847 | +0.06% | ||
| 2026-02-17 | Sale | Central Garden & Pet Company CENT | President, Pet Consumer Prod | 5,000 0.0072% | $34.75 | $173,761 | +11.1% | |
| 2026-02-17 | Cineverse Corp. CNVS | Chief Motion Pictures Officer | 30,000 0.1131% | $2.00 | $60,000 | +35.5% | ||
| 2026-02-17 | Cineverse Corp. CNVS | CFO | 35,000 0.132% | $2.00 | $70,000 | +35.5% | ||
| 2026-02-17 | Cineverse Corp. CNVS | CEO and Chairman | 75,000 0.2828% | $2.00 | $150,000 | +35.5% | ||
| 2026-02-17 | Cineverse Corp. CNVS | Chief People Officer | 25,000 0.0943% | $2.00 | $50,000 | +35.5% | ||
| 2026-02-17 | Cineverse Corp. CNVS | Pres Tech/Chief Product Off | 37,500 0.1414% | $2.00 | $75,000 | +35.5% | ||
| 2026-02-17 | Cineverse Corp. CNVS | CLO, Secretary and Sr Advisor | 30,000 0.1131% | $2.00 | $60,000 | +35.5% | ||
| 2026-02-17 | Cineverse Corp. CNVS | CSO and President | 30,000 0.1131% | $2.00 | $60,000 | +35.5% |